NovaPeptideTesamorelin
Ordered Tesamorelin from NovaPeptide? Mail in a sample (US only) and let us test it.
Test my supplyNovaPeptide Tesamorelin's rating is pulled down by a recent run of sub-99.5% purity results after one 99.9% result. The sharpest miss was 91.99% purity with -46% fill; later 98.5% and 98.9% tests keep the concern from looking isolated.
Two sister domains tell conflicting China-manufacturer and Delaware-biotech stories, while registry and WHOIS records point elsewhere. The report traces the virtual-office address, informal payment rails, and copycat coupon-page confusion buyers must verify.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including NovaPeptide rows.
Cancel anytime
About NovaPeptide test results from Finnrick
NovaPeptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 5 peptides and 24 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible NovaPeptide peptides in this dataset are BPC-157 (3 tests), GHK-Cu (3 tests) and Retatrutide (12 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 24 recent tests.
Ordered Tesamorelin from NovaPeptide? Mail in a sample (US only) and let us test it.
Test my supply